EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Multibacillary leprosy relapse presenting as hypopigmented patches and concurrent erythema nodosum leprosum after initial multidrug therapy

Mildred Min, Yasmin Khalfe, Bonnie Leung, Yve Huttenbach, Vicky Ren

Dermatology Online Journal · 2026

DOI: 10.25251/h89f6543 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Dermatology Online Journal, 2026. Verfasst von Mildred Min und 4 weiteren Autor:innen. Beteiligte Einrichtung: California Northstate University College of Medicine, Elk Grove, CA, USA. Hauptthemen laut MEDLINE: Erythema Nodosum, Leprostatic Agents, Leprosy, Lepromatous, Leprosy, Multibacillary. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leprosy is a chronic granulomatous disease of the skin, peripheral nerves, and mucosal membranes caused by Mycobacterium leprae. Although curable with multidrug therapy (MDT), relapse, reinfection, or immunologic reactions can occur. Leprosy reactions are abnormal immune responses ranging from type IV hypersensitivity to immune-complex–mediated phenomena, such as erythema nodosum leprosum (ENL). We report a 23-year-old man who completed MDT for multibacillary leprosy 1 year prior and presented with a 2-week history of tender, erythematous subcutaneous nodules, systemic symptoms, and pre-existing hypopigmented patches. Imaging revealed lymphadenopathy and splenomegaly, suggesting systemic inflammation. Biopsies showed granulomatous collections of epithelioid to foamy histiocytes centered on dermal nerve bundles and adnexal structures, with focal early vasculitic changes and scattered neutrophils. Fite-Faraco staining demonstrated numerous weakly acid-fast bacilli. These findings were consistent with leprosy relapse and concurrent ENL. Treatment was initiated with monthly rifampin, moxifloxacin, and minocycline (RMM), alongside methotrexate and prednisone. This case highlights an unusual presentation of leprosy relapse with concurrent ENL following completion of MDT. Ongoing surveillance and follow-up are essential to monitor for relapse, reinfection, and reactions, particularly in high-risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erythema NodosumLeprostatic AgentsLeprosy, LepromatousLeprosy, MultibacillaryHypopigmentationHumansMaleRecurrenceYoung AdultDrug Therapy, CombinationMinocyclineMethotrexateRifampinMoxifloxacinPrednisoneMycobacterium leprae

Stichwörter der Autor:innen

erythema nodosum leprosumlepromatous leprosymultidrug therapyreactionrelapse

Substanzen

Leprostatic AgentsMinocyclineMethotrexateRifampinMoxifloxacinPrednisone

Autor:innen und Institutionen

  • California Northstate University College of Medicine, Elk Grove, CA, USA.
  • Department of Dermatology, Baylor College of Medicine, Houston, TX, USA.
  • Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.

Zitieren

APA

Min, M., Khalfe, Y., Leung, B., Huttenbach, Y., & Ren, V. (2026). Multibacillary leprosy relapse presenting as hypopigmented patches and concurrent erythema nodosum leprosum after initial multidrug therapy. Dermatology Online Journal. https://doi.org/10.25251/h89f6543

Vancouver

Min M, Khalfe Y, Leung B, Huttenbach Y, Ren V. Multibacillary leprosy relapse presenting as hypopigmented patches and concurrent erythema nodosum leprosum after initial multidrug therapy. Dermatology Online Journal. 2026. doi:10.25251/h89f6543

BibTeX
@article{Min2026,
  author = {Min, Mildred and Khalfe, Yasmin and Leung, Bonnie and Huttenbach, Yve and Ren, Vicky},
  title = {Multibacillary leprosy relapse presenting as hypopigmented patches and concurrent erythema nodosum leprosum after initial multidrug therapy},
  journal = {Dermatology Online Journal},
  year = {2026},
  doi = {10.25251/h89f6543}
}
Kostenlos starten →